The Lancet Respiratory Medicine in conversation with

The Changing Concerns of Pulmonary Disease: The Lancet Respiratory Medicine: April 25, 2016


Listen Later

Dr. Dirkje Postma of the National Program of Lung Research discusses the changing face of pulmonary disease research.

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

...more
View all episodesView all episodes
Download on the App Store

The Lancet Respiratory Medicine in conversation withBy The Lancet Group

  • 5
  • 5
  • 5
  • 5
  • 5

5

1 ratings


More shows like The Lancet Respiratory Medicine in conversation with

View all
JAMA Editors' Summary by JAMA Network

JAMA Editors' Summary

131 Listeners

This Week in Virology by Vincent Racaniello

This Week in Virology

2,052 Listeners

Thorax Podcast by BMJ Group

Thorax Podcast

3 Listeners

NEJM This Week by NEJM Group

NEJM This Week

325 Listeners

Out of the Blue: An AJRCCM Podcast by American Thoracic Society

Out of the Blue: An AJRCCM Podcast

34 Listeners

JAMA Clinical Reviews by JAMA Network

JAMA Clinical Reviews

496 Listeners

The Lancet Voice by The Lancet Group

The Lancet Voice

23 Listeners

JAMAevidence JAMA Guide to Statistics and Methods by JAMA Network

JAMAevidence JAMA Guide to Statistics and Methods

20 Listeners

The Lancet Child & Adolescent Health in conversation with by The Lancet Group

The Lancet Child & Adolescent Health in conversation with

0 Listeners

The Lancet Digital Health in conversation with by The Lancet Group

The Lancet Digital Health in conversation with

0 Listeners

The Lancet Global Health in conversation with by The Lancet Group

The Lancet Global Health in conversation with

2 Listeners

The Lancet Oncology in conversation with by The Lancet Group

The Lancet Oncology in conversation with

1 Listeners

The Lancet Psychiatry in conversation with by The Lancet Group

The Lancet Psychiatry in conversation with

0 Listeners

The Lancet in conversation with by The Lancet Group

The Lancet in conversation with

1 Listeners

The Lancet Haematology in conversation with by The Lancet Group

The Lancet Haematology in conversation with

0 Listeners

The Ezra Klein Show by New York Times Opinion

The Ezra Klein Show

15,335 Listeners

The Lancet Gastroenterology & Hepatology in conversation with by The Lancet Group

The Lancet Gastroenterology & Hepatology in conversation with

0 Listeners

The Lancet Diabetes & Endocrinology in conversation with by The Lancet Group

The Lancet Diabetes & Endocrinology in conversation with

1 Listeners

The Lancet Infectious Diseases in conversation with by The Lancet Group

The Lancet Infectious Diseases in conversation with

0 Listeners

The Lancet Public Health in conversation with by The Lancet Group

The Lancet Public Health in conversation with

1 Listeners

The Lancet Microbe in conversation with by The Lancet Group

The Lancet Microbe in conversation with

0 Listeners

In conversation with... by The Lancet Neurology

In conversation with...

0 Listeners

eBioMedicine in conversation with by The Lancet Group

eBioMedicine in conversation with

0 Listeners

ID:IOTS - Infectious Disease Insight Of Two Specialists by Infectious Disease: Insights of Two Specialists

ID:IOTS - Infectious Disease Insight Of Two Specialists

24 Listeners

eClinicalMedicine in conversation with by The Lancet Group

eClinicalMedicine in conversation with

0 Listeners

The Lancet Rheumatology in conversation with by The Lancet Group

The Lancet Rheumatology in conversation with

0 Listeners

The Lancet Regional Health in conversation with by The Lancet Group

The Lancet Regional Health in conversation with

0 Listeners

The Rest Is Entertainment by Goalhanger

The Rest Is Entertainment

819 Listeners

The Rest Is Politics: US by Goalhanger

The Rest Is Politics: US

2,300 Listeners

The Lancet Regional Health Americas in conversation with by The Lancet Group

The Lancet Regional Health Americas in conversation with

0 Listeners